Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, and Head of Development
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Revenue increased 11.4 per cent to Rs. 8,545 crore
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Subscribe To Our Newsletter & Stay Updated